See more : Jetpak Top Holding AB (publ) (JETPAK.ST) Income Statement Analysis – Financial Results
Complete financial analysis of AdaptHealth Corp. (AHCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AdaptHealth Corp., a leading company in the Medical – Devices industry within the Healthcare sector.
- High-Tech Metals Limited (HTM.AX) Income Statement Analysis – Financial Results
- Bravo Multinational Incorporated (BRVO) Income Statement Analysis – Financial Results
- USU Software AG (OSP2.DE) Income Statement Analysis – Financial Results
- Xiamen Tungsten Co., Ltd. (600549.SS) Income Statement Analysis – Financial Results
- Intellia Therapeutics, Inc. (NTLA) Income Statement Analysis – Financial Results
AdaptHealth Corp. (AHCO)
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.20B | 2.97B | 2.45B | 1.06B | 529.64M | 345.28M | 192.56M | 174.32M |
| Cost of Revenue | 2.72B | 2.55B | 2.01B | 895.16M | 439.85M | 285.20M | 162.90M | 158.69M |
| Gross Profit | 479.56M | 417.43M | 445.61M | 161.23M | 89.80M | 60.08M | 29.66M | 15.63M |
| Gross Profit Ratio | 14.99% | 14.05% | 18.15% | 15.26% | 16.95% | 17.40% | 15.40% | 8.96% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 310.00K | 0.00 |
| General & Administrative | 190.09M | 162.13M | 167.51M | 89.35M | 56.49M | 1.04M | 9.00M | 8.00M |
| Selling & Marketing | 0.00 | 19.20M | 18.50M | 5.30M | -12.13M | 1.79M | 482.74K | 399.23K |
| SG&A | 190.09M | 162.13M | 167.51M | 89.35M | 44.36M | 1.04M | 693.00 | 11.40M |
| Other Expenses | 887.87M | 64.89M | 52.50M | -2.90M | 135.00K | 197.59K | 0.00 | 0.00 |
| Operating Expenses | 1.08B | 227.02M | 220.01M | 86.44M | 44.36M | 1.23M | 693.00 | 13.30M |
| Cost & Expenses | 3.80B | 2.78B | 2.23B | 981.60M | 157.70M | 1.23M | 693.00 | 171.99M |
| Interest Income | 0.00 | 109.41M | 95.20M | 41.43M | 39.30M | 4.15M | 0.00 | 5.76M |
| Interest Expense | 130.30M | 109.41M | 95.20M | 41.43M | 13.26M | 4.15M | 0.00 | 0.00 |
| Depreciation & Amortization | 420.59M | 423.44M | 333.18M | 82.45M | 62.57M | 50.61M | 27.82M | 26.56M |
| EBITDA | -171.09M | 630.76M | 483.66M | -82.17M | 110.30M | 80.85M | 43.90M | 28.89M |
| EBITDA Ratio | -5.35% | 18.22% | 19.63% | -1.19% | 7.00% | -0.36% | 0.00% | 16.57% |
| Operating Income | -598.40M | 190.41M | 225.61M | 74.79M | 29.70M | -1.23M | -690.00 | 2.32M |
| Operating Income Ratio | -18.70% | 6.41% | 9.19% | 7.08% | 5.61% | -0.36% | 0.00% | 1.33% |
| Total Other Income/Expenses | -125.38M | -92.51M | -34.65M | -277.39M | -51.24M | -8.85M | 0.00 | -5.76M |
| Income Before Tax | -723.78M | 97.90M | 190.96M | -70.67M | 12.53M | 2.92M | -693.00 | -3.44M |
| Income Before Tax Ratio | -22.62% | 3.30% | 7.78% | -6.69% | 2.37% | 0.84% | 0.00% | -1.97% |
| Income Tax Expense | -49.00M | 24.77M | 32.81M | -11.96M | 294.00K | 829.81K | 248.81K | 208.45K |
| Net Income | -678.90M | 69.32M | 156.18M | -58.72M | 12.24M | 2.09M | -693.00 | -3.79M |
| Net Income Ratio | -21.21% | 2.33% | 6.36% | -5.56% | 2.31% | 0.60% | 0.00% | -2.18% |
| EPS | -5.32 | 0.52 | 1.12 | -1.12 | 0.54 | 0.07 | 0.00 | -0.12 |
| EPS Diluted | -5.31 | 0.50 | 0.67 | -1.12 | 0.54 | 0.07 | 0.00 | -0.12 |
| Weighted Avg Shares Out | 134.16M | 134.18M | 133.03M | 52.48M | 22.46M | 31.25M | 31.25M | 31.25M |
| Weighted Avg Shares Out (Dil) | 134.42M | 138.99M | 133.03M | 52.49M | 22.56M | 31.25M | 31.25M | 31.25M |
AdaptHealth Corp. to Participate in the BofA Securities Home Care Conference 2024
AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference
These Analysts Lower Their Forecasts On AdaptHealth Following Weak Sales
Why AdaptHealth Stock Got Thrashed on Tuesday
AdaptHealth Corp. (AHCO) Q3 2024 Earnings Call Transcript
AdaptHealth Corp. (AHCO) Surpasses Q3 Earnings Estimates
AHCO or LZAGY: Which Is the Better Value Stock Right Now?
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
Are Investors Undervaluing AdaptHealth (AHCO) Right Now?
AdaptHealth Corp. Announces Third Quarter 2024 Earnings Release Date and Conference Call
Source: https://incomestatements.info
Category: Stock Reports